Exact Therapeutics
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
123 Demo St, New York, New York, 12345, ...Website
www.exact-tx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Exact Therapeutics
EXACT Therapeutics is a biotech company focused on developing targeted oncology treatments using ultrasound technology. Their key product, PS101, is an investigational pro-drug designed to enhance drug delivery to tumors, particularly in the treatment of locally advanced pancreatic cancer. The company is actively conducting clinical trials, including the Phase 2 ENACT trial, to evaluate the safety and efficacy of their innovative therapies. Their intended clients include patients with cancer, healthcare providers, and investors interested in cutting-edge cancer treatment solutions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Exact Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Exact Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Exact Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Exact Therapeutics launches new products
Funding: Get notified immidiatlly once Exact Therapeutics has new funding data
Earning: See what the market has to say on Exact Therapeutics recently announced quarterly report
Check if Exact Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Exact Therapeutics
Check out if Exact Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Exact Therapeutics
Find 3 more new buyers
Compare Similar Companies to Exact Therapeutics
Compare insights from companies similar to Exact Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Exact Therapeutics
<$5M
1-10
Private
-
2012
N/A
Company Profile Activity
Activity Insights
Exact Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Exact Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Exact Therapeutics.
Exact Therapeutics Tech Stack
A closer look at the technologies used by Exact Therapeutics
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Person-Based
Exact Therapeutics News & Media
EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer
OSLO, Norway, June 24, 2025 (GLOBE NEWSWIRE) -- EXACT Therapeutics (Euronext Growth: EXTX), a clinical-stage precision medicine company, is pleased to announce first patient dosed in its ENACT trial.EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer
OSLO, Norway, May 20, 2025 (GLOBE NEWSWIRE) -- EXACT Therapeutics (Euronext Growth: EXTX), a clinical-stage precision medicine company, is pleased to announce the final and positive data set from its Phase 1 ACTIVATE trial. The trial investigated the use of EXACT’s proprietary Acoustic Cluster Therapy with chemotherapy in hard-to-treat patients with liver metastases of colorectal origin. These encouraging clinical data provide proof of principle for the clinical application of ACT technology andCordance Medical and EXACT Therapeutics Announce Early Encouraging Data in Brain Cancer Mice Model
MOUNTAIN VIEW, Calif. and OSLO, Norway, Jan. 28, 2025 /PRNewswire/ -- Cordance Medical, a pioneer in non-invasive medical technologies for brain disease treatment, and EXACT Therapeutics (Euronext Growth: EXTX), a clinical-stage precision medicine company, are pleased to announce initial...EXACT Therapeutics Receives Investment from GE HealthCare to Advance ... - TradingView
Oslo, Norway; December 02, 2024 - EXACT Therapeutics Receives Investment fromGEHealthCare to Advance Therapeutic Ultrasound in Pancreatic Cancer using ACT®* GE HealthCare to participate as cornerstone investor and invest 7 MUSD in aprivate placement in EXACT Therapeutics* Anticipated that the priva…
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Exact Therapeutics
Sign Up For FreeTo access detailed company insights
EXACT Therapeutics is a biotech company focused on developing targeted oncology treatments using ultrasound technology. Their key product, PS101, is an investigational pro-drug designed to enhance drug delivery to tumors, particularly in the treatment of locally advanced pancreatic cancer. The company is actively conducting clinical trials, includi... Read More
